UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
Tesla
TSLA
|
+$448M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$344M |
| 3 |
Exxon Mobil
XOM
|
+$302M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$234M |
| 5 |
TSMC
TSM
|
+$231M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$924M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$837M |
| 3 |
UBS Group
UBS
|
+$706M |
| 4 |
NLSN
Nielsen Holdings plc
NLSN
|
+$462M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$388M |
Sector Composition
| 1 | Technology | 16.77% |
| 2 | Financials | 9.21% |
| 3 | Healthcare | 8.14% |
| 4 | Consumer Discretionary | 7.12% |
| 5 | Industrials | 5.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITOS
1851
DELISTED
iTeos Therapeutics
ITOS
| $5.49M | ﹤0.01% |
170,690
+132,934
| +352% | +$4.28M |
|
1852
PotlatchDeltic
PCH
$3.2B
| $5.49M | ﹤0.01% |
104,160
-19,462
| -16% | -$1.03M |
|
|
DEN
1853
DELISTED
Denbury Inc.
DEN
| $5.49M | ﹤0.01% |
69,851
-26,188
| -27% | -$2.06M |
|
1854
Exelixis
EXEL
$10.5B
| $5.49M | ﹤0.01% |
242,097
-383,276
| -61% | -$8.69M |
|
1855
Celldex Therapeutics
CLDX
$1.62B
| $5.48M | ﹤0.01% |
160,779
+30,189
| +23% | +$1.03M |
|
1856
Corcept Therapeutics
CORT
$7.68B
| $5.47M | ﹤0.01% |
242,991
+3,415
| +1% | +$76.9K |
|
|
EIM
1857
Eaton Vance Municipal Bond Fund
EIM
$515M
| $5.46M | ﹤0.01% |
474,332
-7,519
| -2% | -$86.5K |
|
1858
Arcturus Therapeutics
ARCT
$470M
| $5.45M | ﹤0.01% |
202,235
+103,205
| +104% | +$2.78M |
|
1859
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.6B
| $5.44M | ﹤0.01% |
548,942
-11,918
| -2% | -$118K |
|
1860
Repligen
RGEN
$6.39B
| $5.44M | ﹤0.01% |
28,897
-26,017
| -47% | -$4.89M |
|
1861
La-Z-Boy
LZB
$1.39B
| $5.43M | ﹤0.01% |
205,902
-50,847
| -20% | -$1.34M |
|
1862
iShares Intermediate Government/Credit Bond ETF
GVI
$3.55B
| $5.43M | ﹤0.01% |
50,014
-13,929
| -22% | -$1.51M |
|
1863
Goldman Sachs Hedge Industry VIP ETF
GVIP
$390M
| $5.43M | ﹤0.01% |
58,866
-11,815
| -17% | -$1.09M |
|
1864
AMN Healthcare
AMN
$699M
| $5.42M | ﹤0.01% |
51,929
-27,836
| -35% | -$2.9M |
|
1865
Ironwood Pharmaceuticals
IRWD
$213M
| $5.41M | ﹤0.01% |
430,231
-28,067
| -6% | -$353K |
|
1866
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.14B
| $5.41M | ﹤0.01% |
117,303
-5,085
| -4% | -$235K |
|
1867
Fate Therapeutics
FATE
$111M
| $5.41M | ﹤0.01% |
139,513
+11,513
| +9% | +$446K |
|
1868
Invesco Energy Exploration & Production ETF
PXE
$71.4M
| $5.41M | ﹤0.01% |
194,916
+19,642
| +11% | +$545K |
|
1869
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$97M
| $5.4M | ﹤0.01% |
120,435
-52,092
| -30% | -$2.34M |
|
1870
SPDR Bloomberg Barclays International Treasury Bond ETF
BWX
$1.38B
| $5.4M | ﹤0.01% |
207,430
-54,447
| -21% | -$1.42M |
|
1871
Perdoceo Education
PRDO
$2.26B
| $5.4M | ﹤0.01% |
470,055
+9,245
| +2% | +$106K |
|
1872
Sleep Number
SNBR
$214M
| $5.39M | ﹤0.01% |
106,327
+42,406
| +66% | +$2.15M |
|
1873
Henry Schein
HSIC
$8.37B
| $5.39M | ﹤0.01% |
61,798
-27,061
| -30% | -$2.36M |
|
1874
BJs Wholesale Club
BJ
$13B
| $5.37M | ﹤0.01% |
79,456
-135,623
| -63% | -$9.17M |
|
1875
NMI Holdings
NMIH
$3.08B
| $5.37M | ﹤0.01% |
260,348
-8,840
| -3% | -$182K |
|